Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Orexo AB
C5GCurrent price
1.62 EUR
0 EUR (0.00%)
Last closed
19.38 SEK
Company
www.orexo.com
ISIN
SE0000736415
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Berlin Exchange
Capitalization
666 975 837 SEK
Yield for 12 month
+35.80 %
1Y
3Y
5Y
10Y
15Y
C5G
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden. Address: Rapsgatan 7E, Uppsala, Sweden
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
220.92 SEKP/E ratio
–Dividend Yield
–Current Year
+637 142 716 SEK
Last Year
+622 680 341 SEK
Current Quarter
+136 145 867 SEK
Last Quarter
+153 600 466 SEK
Current Year
+548 473 359 SEK
Last Year
+520 346 522 SEK
Current Quarter
+116 098 013 SEK
Last Quarter
+116 596 722 SEK
Key Figures C5G
1 year
3 years
5 years
10 years
EBITDA
67 624 106 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.12 %
PEG Ratio
–
Return On Equity TTM
-325.00 %
Wall Street Target Price
220.92 SEK
Revenue TTM
594 154 504 SEK
Book Value
-0.79 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-12.60 %
Dividend Yield
–
Gross Profit TTM
524 535 623 SEK
Earnings per share
-3.04 SEK
Diluted Eps TTM
-3.04 SEK
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
485.00 %
Profit Margin
-17.68 %
Dividend Analytics C5G
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History C5G
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1904:1903
Payout Ratio
–
Last Split Date
31.05.2011
Dividend Date
–
Stock Valuation C5G
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
9.16
Enterprise Value Revenue
1.93
Price Sales TTM
1.12
Enterprise Value EBITDA
26.71
Price Book MRQ
21.07
Financials C5G
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators C5G
For 52 weeks
9.16 SEK
23.94 SEK
50 Day MA
14.89 SEK
Shares Short Prior Month
–
200 Day MA
16.40 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart